2,810
Views
37
CrossRef citations to date
0
Altmetric
Research Paper

Analysis of imidazoles and triazoles in biological samples after MicroExtraction by packed sorbent

, ORCID Icon, , , , , , , & show all
Pages 1053-1063 | Received 09 Jun 2017, Accepted 10 Jul 2017, Published online: 04 Aug 2017

References

  • Shalmali N, Ali MR, Bawa S. Imidazole: an essential edifice for the identification of new lead compounds and drug development. Mini Rev Med Chem 2017. [E-pub ahead of print]. doi: 10.2174/1389557517666170228113656
  • Riviere JE, Papich MG, Veterinary pharmacology and therapeutics. 9th ed. Hoboken: John Wiley & Sons; 2009.
  • Ekiert RJ, Krzek J, Talik P. Chromatographic and electrophoretic techniques used in the analysis of triazole antifungal agents—a review. Talanta 2010;82:1090–100.
  • Gidaro MC, Alcaro S, Secci D, et al. Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening. J Enzyme Inhib Med Chem 2016;31:1703–6.
  • Secci D, Carradori S, Bizzarri B, et al. Novel 1,3-thiazolidin-4-one derivatives as promising anti-Candida agents endowed with anti-oxidant and chelating properties. Eur J Med Chem 2016;117:144–56.
  • De Monte C, Carradori S, Bizzarri B, et al. Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives. Eur J Med Chem 2016;107:82–96.
  • Carradori S, Secci D, Bolasco A, et al. Synthesis and cytotoxicity of novel (thiazol-2-yl)hydrazine derivatives as promising anti-Candida agents. Eur J Med Chem 2013;65:102–11.
  • Secci D, Bizzarri B, Bolasco A, et al. Synthesis, anti-Candida activity, and cytotoxicity of new (4-(4-iodophenyl)thiazol-2-yl)hydrazine derivatives. Eur J Med Chem 2012;53:246–53.
  • Chimenti F, Bizzarri B, Bolasco A, et al. Synthesis and biological evaluation of novel 2,4-disubstituted-1,3-thiazoles as anti-Candida spp. agents. Eur J Med Chem 2011;46:378–82.
  • Chimenti F, Bizzarri B, Maccioni E, et al. Synthesis and in vitro activity of 2-thiazolylhydrazone derivatives compared with the activity of clotrimazole against clinical isolates of Candida spp. Bioorg Med Chem Lett 2007;17:4635–40.
  • Srivatsan V, Dasgupta AK, Kale P, et al. Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by high-performance liquid chromatography. J Chromatogr A 2004;1031:307–13.
  • Michael C, Teichert J, Preiss R. Determination of voriconazole in human plasma and saliva using high-performance liquid chromatography with fluorescence detection. J Chromatogr B 2008;865:74–80.
  • Neubauer W, König A, Bolek R, et al. Determination of the antifungal agent posaconazole in human serum by HPLC with parallel column-switching technique. J Chromatogr B 2009;877:2493–8.
  • Jaruratanasirikul S, Sriwiriyajan S. Pharmacokinetic study of the interaction between itraconazole and nevirapine. Eur J Clin Pharmacol 2007;63:451–6.
  • Kahle K, Langmann P, Schirmer D, et al. Simultaneous determination of voriconazole and posaconazole concentrations in human plasma by high-performance liquid chromatography. Antimicrob Agents Chemother 2009;53:3140–2.
  • Ghosal A, Hapangama N, Yuan Y, et al. Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil). Drug Metab Dispos 2004; 32:267–71.
  • Zhang M, Moore GA, Barclay ML, Begg EJ. A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasma. Antimicrob Agents Chemother 2013;57:484–9.
  • Khalil HA, El-Yazbi AF, Belal TS, Hamdy DA. High performance liquid chromatographic assay for the simultaneous determination of posaconazole and vincristine in rat plasma. Int J Anal Chem 2015;743915.
  • Baietto L, D’Avolio A, Ventimiglia G, et al. Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma. Antimicrob Agents Chemother 2010;54:3408–13.
  • Rhim S-Y, Park J-H, Park Y-S, et al. A sensitive validated LC-MS/MS method for quantification of itraconazole in human plasma for pharmacokinetic and bioequivalence study in 24 Korean volunteers. Pharmazie 2009;64:71–5.
  • Wang G, Lei H-P, Li Z, et al. The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers. Eur J Clin Pharmacol 2009;65:281–5.
  • Conte JE Jr, Golden JA, Krishna G, et al. Intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole at steady state in healthy subjects. Antimicrob Agents Chemother 2009;53:703–7.
  • Brüggemann RJM, Touw DJ, Aarnoutse RE, et al. International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations. Antimicrob Agents Chemother 2009;53:303–5.
  • Kumar V, Wang L, Riebe M, et al. Formulation and stability of itraconazole and odanacatib nanoparticles: governing physical parameters. Mol Pharm 2009;6:1118–24.
  • Gu P, Li Y. Development and validation of a stability-indicating HPLC method for determination of voriconazole and its related substances. J Chromatogr Sci 2009;47:594–8.
  • Al-Badriyeh D, Li J, Stewart K, et al. Stability of extemporaneously prepared voriconazole ophthalmic solution. Am J Health-Syst Pharm 2009;66:1478–83.
  • Chhun S, Rey E, Tran A, et al. Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection. J Chromatogr B 2007;852:223–8.
  • Gordien J-B, Pigneux A, Vigouroux S, et al. Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection. J Pharm Biomed Anal 2009;50:932–8.
  • Gagliardi L, de Orsi D, Chimenti P, et al. HPLC determination of imidazole antimycotis in antidandruff cosmetic products. Anal Sci 2003;19:1195–7.
  • Locatelli M, Cifelli R, Di Legge C, et al. Simultaneous determination of eperisone hydrochloride and paracetamol in mouse plasma by high performance liquid chromatography-PhotoDiode Array Detector. J Chromatogr A 2015;1388:79–86.
  • Locatelli M, Ferrone V, Cifelli R, et al. MicroExtraction by Packed Sorbent and HPLC determination of seven non-steroidal anti-inflammatory drugs in human plasma and urine. J Chromatogr A 2014;1367:1–8.
  • Locatelli M, Ciavarella MT, Paolino D, et al. Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector. J Chromatogr A 2015;1419:58–66.
  • D’Angelo V, Tessari F, Bellagamba G, et al. Microextraction by packed sorbent and HPLC–PDA quantification of multiple anti-inflammatory drugs and fluoroquinolones in human plasma and urine. J Enzyme Inhib Med Chem 2016;31:110–16.
  • Abdel-Rehim M. Recent advances in microextraction by packed sorbent for bioanalysis. J Chromatogr A 2010;1217:2569–80.
  • Mousa BA, El-Kousy NM, El-Bagary RI, Mohamed NG. Stability indicating methods for the determination of some anti-fungal agents using densitometric and RP-HPLC methods. Chem Pharm Bull 2008;56:143–9.
  • CDER and CVM Guidance for Industry, Bioanalytical Method Validation. Food and Drug Administration, May 2001. Available from: http://www.fda.gov\cder\guidance\4252fnl.pdf.
  • International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. Harmonised Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology, ICH Q2(R1); 2005.
  • Taverniers I, Van Bockstaele E, De Loose M. Trends in quality in the analytical laboratory. II. Analytical method validation and quality assurance. Trend Anal Chem 2004;23:535–52.
  • Liang X, Van Parys M, Ding X, et al. Simultaneous determination of itraconazole, hydroxy itraconazole, keto itraconazole and N-desalkyl itraconazole concentration in human plasma using liquid chromatography with tandem mass spectrometry. J Chromatogr B 2016;1020:111–19.
  • Locatelli M, Kabir A, Innosa D, et al. A fabric phase sorptive extraction-high performance liquid chromatography-photo diode array detection method for the determination of twelve azole antimicrobial drug residues in human plasma and urine. J Chromatogr B 2017;1040:192–8.
  • Jourdil J-F, Tonini J, Stanke-Labesque F. Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B 2013;919:1–9.
  • Verweij-van Wissen CPWGM, Burger DM, Verweij PE, et al. Simultaneous determination of the azoles voriconazole, posaconazole, isavuconazole, itraconazole and its metabolite hydroxy-itraconazole in human plasma by reversed phase ultra-performance liquid chromatography with ultraviolet detection. J Chromatogr B 2012;887–888:79–84.
  • Mak J, Sujishi KK, French D. Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay to quantify serum voriconazole. J Chromatogr B 2015;986–987:94–9.
  • Cameron JR, Skofronick JG, Roderick MG. Physics of the body. 2nd ed. Madison (WI): Medical Physics Publishing; 1999.
  • Hardin TC, Graybill JR, Fetchick R, et al. Pharmacokinetics of itraconazole following oral administration to normal volunteers. Antimicrob Agents Chemother 1988;32:1310–3.
  • Domínguez-Gil Hurlé A, Sánchez Navarro A, García Sánchez MJ. Therapeutic drug monitoring of itraconazole and the relevance of pharmacokinetic interactions. Clin Microbiol Infect 2006;12:97–106.
  • Available from: http://www.inchem.org/documents/pims/pharm/miconazo.htm#SectionTitle:5.1 Oral; [last accessed 10 Jul 2017].
  • Available from: http://www.drugsupdate.com/generic/view/311/Miconazole; [last accessed 10 Jul 2017].